SEARCH RESULTS for NOVARTIS AG

Recent Patent Assignments Patent Assignments - (Total found: 251)

Last Update Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame
23-Nov-2017

(X0) 15591727: VITRECTOMY PROBE WITH END TISSUE CUTTER AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS

(A1) 20170333252: VITRECTOMY PROBE WITH END TISSUE CUTTER AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS

ALCON RESEARCH, LTD.

NOVARTIS AG

43239/509

23-Nov-2017

(X0) 15591498: AUTOMATED VISCOUS FLUID CONTROL IN VITREORETINAL SURGERY

(A1) 20170333253: AUTOMATED VISCOUS FLUID CONTROL IN VITREORETINAL SURGERY

ALCON RESEARCH, LTD.

NOVARTIS AG

43239/666

23-Nov-2017

(X0) 15159079: DUAL ELEMENT ACCOMMODATING INTRAOCULAR LENS DEVICES, SYSTEMS, AND METHODS

(A1) 20170333181: DUAL ELEMENT ACCOMMODATING INTRAOCULAR LENS DEVICES, SYSTEMS, AND METHODS

ALCON RESEARCH, LTD.

NOVARTIS AG

38647/537

20-Nov-2017

(X0) 14566471: VALVES, DEVICES, AND METHODS FOR ENDOBRONCHIAL THERAPY

(A1) 20150114504: VALVES, DEVICES, AND METHODS FOR ENDOBRONCHIAL THERAPY

NOVARTIS PHARMA AG

NOVARTIS AG

44164/512

16-Nov-2017

(X0) 15321065: COMPOSITIONS AND METHODS FOR LONG ACTING PROTEINS

(A1) 20170327553: COMPOSITIONS AND METHODS FOR LONG ACTING PROTEINS

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

NOVARTIS AG

41050/46

16-Nov-2017

(X0) 15094077: Hyperblebbing Shigella Strains

(A1) 20160289632: Hyperblebbing Shigella Strains

GSK VACCINES INSTITUTE FOR GLOBAL HEALTH S.R.L.

NOVARTIS AG

44127/918

16-Nov-2017

(X0) 15287891: CELL PROLIFERATION INHIBITORS AND CONJUGATES THEREOF

(A1) 20170326250: CELL PROLIFERATION INHIBITORS AND CONJUGATES THEREOF

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

NOVARTIS AG

42253/932

16-Nov-2017

(X0) 15321065: COMPOSITIONS AND METHODS FOR LONG ACTING PROTEINS

(A1) 20170327553: COMPOSITIONS AND METHODS FOR LONG ACTING PROTEINS

NOVARTIS PHARMA AG

NOVARTIS AG

41049/21

16-Nov-2017

(X0) 15287891: CELL PROLIFERATION INHIBITORS AND CONJUGATES THEREOF

(A1) 20170326250: CELL PROLIFERATION INHIBITORS AND CONJUGATES THEREOF

NOVARTIS PHARMA AG

NOVARTIS AG

42254/113

16-Nov-2017

(X0) 15590084: AUTOMATED ASPIRATION THROTTLING IN VITREORETINAL SURGERY

(A1) 20170326000: AUTOMATED ASPIRATION THROTTLING IN VITREORETINAL SURGERY

ALCON RESEARCH, LTD.

NOVARTIS AG

42293/918

14-Nov-2017

(X0) 15202759: SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES

(A1) 20160377885: SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES

(B2) 9816009: SILICONE HYDROGEL LENSES WITH WATER-RICH SURFACES

QIU, YONGXING

PRUITT, JOHN DALLAS

THEKVELI, SIBICHEN J.

TUCKER, ROBERT CAREY

NELSON, JARED

N/A

NOVARTIS AG

39132/808

14-Nov-2017

(X0) 14409871: COMPLEMENT PATHWAY MODULATORS AND USES THEREOF

(A1) 20150141455: COMPLEMENT PATHWAY MODULATORS AND USES THEREOF

(B2) 9815819: COMPLEMENT PATHWAY MODULATORS AND USES THEREOF

NOVARTIS PHARMA AG

N/A

NOVARTIS AG

37240/469

14-Nov-2017

(X0) 14830392: TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

(A1) 20160068601: TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

(B2) 9815901: TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH

N/A

NOVARTIS AG

42545/890

14-Nov-2017

(X0) 14830392: TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

(A1) 20160068601: TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

(B2) 9815901: TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

N/A

NOVARTIS AG

42545/921

14-Nov-2017

(X0) 15312321: PYRAZOLO PYRIMIDINE DERIVATIVES AND THEIR USE AS MALT1 INHBITORS

(A1) 20170121335: PYRAZOLO PYRIMIDINE DERIVATIVES AND THEIR USE AS MALT1 INHBITORS

(B2) 9815842: PYRAZOLO PYRIMIDINE DERIVATIVES AND THEIR USE AS MALT1 INHBITORS

NOVARTIS PHARMA AG

N/A

NOVARTIS AG

42459/957

09-Nov-2017

(X0) 15658063: OPHTHALMIC DEVICE HAVING THERAPEUTIC AGENT DELIVERY CAPABILITY AND METHOD OF FORMING SAME

(A1) 20170319474: OPHTHALMIC DEVICE HAVING THERAPEUTIC AGENT DELIVERY CAPABILITY AND METHOD OF FORMING SAME

ALCON, INC.

NOVARTIS AG

43333/778

07-Nov-2017

(X0) 14439238: FLAVIVIRUS ASSOCIATED WITH THEILER'S DISEASE

(A1) 20150292042: FLAVIVIRUS ASSOCIATED WITH THEILER'S DISEASE

(B2) 9809863: FLAVIVIRUS ASSOCIATED WITH THEILER'S DISEASE

NOVARTIS ANIMAL HEALTH US, INC.

N/A

NOVARTIS AG

35618/870

07-Nov-2017

(X0) 15249587: METHOD FOR PRODUCING CONTACT LENSES WITH DURABLE LUBRICIOUS COATINGS THEREON

(A1) 20170068019: METHOD FOR PRODUCING CONTACT LENSES WITH DURABLE LUBRICIOUS COATINGS THEREON

(B2) 9810812: METHOD FOR PRODUCING CONTACT LENSES WITH DURABLE LUBRICIOUS COATINGS THEREON

ALCON RESEARCH, LTD.

N/A

NOVARTIS AG

39737/840

07-Nov-2017

(X0) 15397787: COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS

(A1) 20170114083: COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS

(B2) 9809610: COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS

NOVARTIS VACCINES AND DIAGNOSTICS, INC.

N/A

NOVARTIS AG

42060/466

07-Nov-2017

(X0) 14439238: FLAVIVIRUS ASSOCIATED WITH THEILER'S DISEASE

(A1) 20150292042: FLAVIVIRUS ASSOCIATED WITH THEILER'S DISEASE

(B2) 9809863: FLAVIVIRUS ASSOCIATED WITH THEILER'S DISEASE

NOVARTIS ANIMAL HEALTH US INC.

N/A

NOVARTIS AG

32430/414

07-Nov-2017

(X0) 14549636: NOVEL PROCESS FOR MAKING MOLDED DEVICES

(A1) 20150151461: NOVEL PROCESS FOR MAKING MOLDED DEVICES

(B2) 9808966: NOVEL PROCESS FOR MAKING MOLDED DEVICES

CIBA VISION GMBH

N/A

NOVARTIS AG

35509/492

31-Oct-2017

(X0) 11416260: Ophthalmic devices for sustained delivery of active compounds

(A1) 20060251696: Ophthalmic devices for sustained delivery of active compounds

(B2) 9804295: Ophthalmic devices for sustained delivery of active compounds

WINTERTON, LYNN COOK

LALLY, JOHN MARTIN

N/A

NOVARTIS AG

22888/163

31-Oct-2017

9803030: MODIFIED SACCHARIDES

9803030: MODIFIED SACCHARIDES

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

N/A

NOVARTIS AG

22950/680

31-Oct-2017

9803030: MODIFIED SACCHARIDES

9803030: MODIFIED SACCHARIDES

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

N/A

NOVARTIS AG

24122/615

31-Oct-2017

(X0) 14567401: METHOD FOR MAKING CONTACT LENSES

(A1) 20150165653: METHOD FOR MAKING CONTACT LENSES

(B2) 9802339: METHOD FOR MAKING CONTACT LENSES

ALCON RESEARCH, LTD.

N/A

NOVARTIS AG

35162/133

31-Oct-2017

(X0) 13808085: DELIVERY OF RNA TO TRIGGER MULTIPLE IMMUNE PATHWAYS

(A1) 20130177639: DELIVERY OF RNA TO TRIGGER MULTIPLE IMMUNE PATHWAYS

(B2) 9801897: DELIVERY OF RNA TO TRIGGER MULTIPLE IMMUNE PATHWAYS

NOVARTIS VACCINES AND DIAGNOSTICS, INC.

N/A

NOVARTIS AG

30119/431

31-Oct-2017

(X0) 14997207: SALTS OF AZA-BICYCLIC DI-ARYL ETHERS AND METHODS TO MAKE THEM OR THEIR PRECURSORS

(A1) 20160145253: SALTS OF AZA-BICYCLIC DI-ARYL ETHERS AND METHODS TO MAKE THEM OR THEIR PRECURSORS

(B2) 9802931: SALTS OF AZA-BICYCLIC DI-ARYL ETHERS AND METHODS TO MAKE THEM OR THEIR PRECURSORS

NOVARTIS PHARMACEUTICALS CORPORATION

N/A

NOVARTIS AG

38053/984

31-Oct-2017

(X0) 14997207: SALTS OF AZA-BICYCLIC DI-ARYL ETHERS AND METHODS TO MAKE THEM OR THEIR PRECURSORS

(A1) 20160145253: SALTS OF AZA-BICYCLIC DI-ARYL ETHERS AND METHODS TO MAKE THEM OR THEIR PRECURSORS

(B2) 9802931: SALTS OF AZA-BICYCLIC DI-ARYL ETHERS AND METHODS TO MAKE THEM OR THEIR PRECURSORS

NOVARTIS PHARMA AG

N/A

NOVARTIS AG

38053/988

31-Oct-2017

(X0) 15274079: CONTAINER FOR ACCOMMODATING AN OPHTHALMIC LENS DURING A LENS TREATMENT PROCESS

(A1) 20170086553: CONTAINER FOR ACCOMMODATING AN OPHTHALMIC LENS DURING A LENS TREATMENT PROCESS

(B2) 9801445: CONTAINER FOR ACCOMMODATING AN OPHTHALMIC LENS DURING A LENS TREATMENT PROCESS

CIBA VISION GMBH

N/A

NOVARTIS AG

39985/595

31-Oct-2017

(X0) 11416260: Ophthalmic devices for sustained delivery of active compounds

(A1) 20060251696: Ophthalmic devices for sustained delivery of active compounds

(B2) 9804295: Ophthalmic devices for sustained delivery of active compounds

NOVARTIS PHARAMACEUTICALS CORPORATION

N/A

NOVARTIS AG

43021/386

31-Oct-2017

(X0) 14881960: VIRAL VECTORS FOR THE TREATMENT OF RETINAL DYSTROPHY

(A1) 20160097061: VIRAL VECTORS FOR THE TREATMENT OF RETINAL DYSTROPHY

(B2) 9803217: VIRAL VECTORS FOR THE TREATMENT OF RETINAL DYSTROPHY

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

N/A

NOVARTIS AG

37838/691

30-Oct-2017

(X0) 15315579: Pyridopyrimidinedione derivatives

(A1) 20170197959: Pyridopyrimidinedione derivatives

NOVARTIS PHARMA AG

NOVARTIS AG

43967/631

30-Oct-2017

(X0) 15315582: Pyrimido[4,5-b]quinoline-4,5(3H,10H)-dione derivatives

(A1) 20170183341: Pyrimido[4,5-b]quinoline-4,5(3H,10H)-dione derivatives

NOVARTIS PHARMA AG

NOVARTIS AG

43967/829

26-Oct-2017

(X0) 15646617: OPHTHALMIC DEVICES FOR SUSTAINED DELIVERY OF ACTIVE COMPOUNDS

(A1) 20170307780: OPHTHALMIC DEVICES FOR SUSTAINED DELIVERY OF ACTIVE COMPOUNDS

WINTERTON, LYNN COOK

LALLY, JOHN MARTIN

NOVARTIS AG

43215/927

26-Oct-2017

(X0) 15646291: SILICONE HYDROGEL LENS WITH A CROSSLINKED HYDROPHILIC COATING

(A1) 20170306178: SILICONE HYDROGEL LENS WITH A CROSSLINKED HYDROPHILIC COATING

QIU, YONGXING

SAMUEL, NEWTON T.

PRUITT, JOHN DALLAS

KOLLURU, CHANDANA

MEDINA, ARTURO N.

WINTERTON, LYNN COOK

WU, DAQING

QIAN, XINMING

NELSON, JARED

NOVARTIS AG

43292/546

24-Oct-2017

(X0) 14976356: APPARATUS FOR REMOVING AN OPHTHALMIC LENS FROM A MOLD HALF

(A1) 20160167322: APPARATUS FOR REMOVING AN OPHTHALMIC LENS FROM A MOLD HALF

(B2) 9796145: APPARATUS FOR REMOVING AN OPHTHALMIC LENS FROM A MOLD HALF

BIEL, ROGER

LÄSSIG, GÜNTER

N/A

NOVARTIS AG

37828/188

24-Oct-2017

(X0) 14387653: PHARMACEUTICAL DIAGNOSTIC

(A1) 20150111927: PHARMACEUTICAL DIAGNOSTIC

(B2) 9795596: PHARMACEUTICAL DIAGNOSTIC

NOVARTIS PHARMA AG

N/A

NOVARTIS AG

34025/539

24-Oct-2017

9795512: MEASURING MODULE INCLUDING AN INTERFACE FOR COUPLING TO A LASER DEVICE

9795512: MEASURING MODULE INCLUDING AN INTERFACE FOR COUPLING TO A LASER DEVICE

WAVELIGHT GMBH

N/A

N/A

NOVARTIS AG

35087/286

24-Oct-2017

9662009: Imaging Probes and Associated Devices, and Systems Utilizing Ferrofluid-Impregnated Actuators

9226851: MEMS CHECK VALVE CHIP AND METHODS

9283114: SYSTEMS AND METHODS FOR PRIMING A MICROFLUIDIC CHAMBER

9797390: PUMP ROLLER ASSEMBLY WITH FLEXIBLE ARMS

9730834: Variable Stiffness Cannula and Methods for a Surgical System

9797391: PUMP ROLLER ASSEMBLY WITH INDEPENDENTLY SPRUNG PIVOTING ROLLERS

9291159: PUMP HEAD WITH INDEPENDENTLY SPRUNG OFFSET PICOTING ROLLERS

9624921: PUMP ROLLER HEAD WITH PIVOTING ROLLERS AND SPRING ARMS

9597009: Marker-Based Tool Tracking

9402534: Two Dimensional Forward Scanning Probe

9308128: MULTI-SPOT LASER PROBE WITH MICRO-STRUCTURED FACETED PROXIMAL SURFACE

9549850: Partial Venting System for Occlusion Surge Mitigation

9606350: FORWARD SCANNING OPTICAL PROBES

9474447: Anamorphic Lens for Rotational Scanning Surgical Laser Probe

9339178: Forward Scanning Optical Probes and Associated Devices, Systems, and Methods

9538911: Integrated OCT-Refractometer System for Ocular Biometry

9283115: PASSIVE TO ACTIVE STAGED DRAINAGE DEVICE

9289324: EXTERNALLY ADJUSTABLE PASSIVE DRAINAGE DEVICE

ALCON RESEARCH LTD.

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

NOVARTIS AG

32093/180

24-Oct-2017

(X0) 14974318: COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING BMP6

(A1) 20160176956: COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING BMP6

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

NOVARTIS AG

43922/241

19-Oct-2017

(X0) 15515621: Pharmaceutical Compositions Comprising Alpelisib

(A1) 20170296523: Pharmaceutical Compositions Comprising Alpelisib

NOVARTIS PHARMA AG

NOVARTIS AG

43151/744

19-Oct-2017

(X0) 15630679: Immunogenic Proteins and Compositions

(A1) 20170296645: Immunogenic Proteins and Compositions

NOVARTIS VACCINES AND DIAGNOSTICS SRL

NOVARTIS AG

42981/15

19-Oct-2017

(X0) 15516655: COMBINATION OF HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES

(A1) 20170296650: COMBINATION OF HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

NOVARTIS AG

42757/958

17-Oct-2017

9314464: COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

9181235: SUBSTITUTED PYRIDINES FOR MODULATING THE WNT SIGNALING PATHWAY

9023791: FIBROBLAST GROWTH FACTOR 21 MUTATIONS

9458214: DUAL FUNCTION FIBROBLAST GROWTH FACTOR 21 PROTEINS

9751876: BICYCLIC HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

9512222: LECTIN-LIKE OXIDIZED LDL RECEPTOR 1 ANTIBODIES AND METHODS OF USE

9498540: CELL PROLIFERATION INHIBITORS AND CONJUGATES THEREOF

9073921: SOLID FORMS OF BICYCLIC HETEROCYCLIC DERIVATIVES

9340582: BIOCONJUGATES OF SYNTHETIC APELIN POLYPEPTIDES

7169817: BIS-AROMATIC ALKANOLS

7893074: 2, 4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS

8552002: COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

8592432: COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

7563894: DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS

7638523: DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS

7592349: DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS

7514447: DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS

8466167: COMPOUNDS AND COMPOSITIONS AS TLR ACTIVITY MODULATORS

8895577: COMPOUNDS AND COMPOSITIONS AS TLR ACTIVITY MODULATORS

8202876: COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

8501758: COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

8859548: Compounds and Compositions as Protein Kinase Inhibitors

8563553: COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

8242260: COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

8710192: PCSK9 ANTAGONISTS

8883819: BICYCLIC HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

8871754: COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES

9556169: COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES

9789203: ANTIBODY DRUG CONJUGATES

NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

NOVARTIS AG

35469/858

17-Oct-2017

(X0) 15532087: COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PROSTATE CANCER

(A1) 20170283807: COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PROSTATE CANCER

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

NOVARTIS AG

43866/336

17-Oct-2017

(X0) 14774512: ANTIBODY DRUG CONJUGATES

(A1) 20160030594: ANTIBODY DRUG CONJUGATES

(B2) 9789203: ANTIBODY DRUG CONJUGATES

NOVARTIS PHARMACEUTICALS UK LIMITED

N/A

NOVARTIS AG

37064/478

17-Oct-2017

(X0) 14774512: ANTIBODY DRUG CONJUGATES

(A1) 20160030594: ANTIBODY DRUG CONJUGATES

(B2) 9789203: ANTIBODY DRUG CONJUGATES

MORPHOSYS AG

N/A

NOVARTIS AG

37064/764

17-Oct-2017

(X0) 14354280: MONOCLONAL CANINE CD20 ANTIBODIES AND METHODS OF USE

(A1) 20150125453: MONOCLONAL CANINE CD20 ANTIBODIES AND METHODS OF USE

(B2) 9790280: MONOCLONAL CANINE CD20 ANTIBODIES AND METHODS OF USE

NOVARTIS ANIMAL HEALTH US, INC.

N/A

NOVARTIS AG

32802/872

17-Oct-2017

(X0) 14774512: ANTIBODY DRUG CONJUGATES

(A1) 20160030594: ANTIBODY DRUG CONJUGATES

(B2) 9789203: ANTIBODY DRUG CONJUGATES

NOVARTIS VACCINES AND DIAGNOSTICS, INC.

N/A

NOVARTIS AG

37069/933

11-Oct-2017

(X0) 15292088: LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF

(A1) 20170281753: LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.

NOVARTIS AG

43828/102